Report Detail
Global Anti-Obesity Prescription Drugs Market Insights and Forecast to 2026
- RnM4130876 |
- 12 August, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Obesity Prescription Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Prescription Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Obesity Prescription Drugs market is segmented into
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Segment by Application, the Anti-Obesity Prescription Drugs market is segmented into
Pediatric
Adult
Regional and Country-level Analysis
The Anti-Obesity Prescription Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Obesity Prescription Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Obesity Prescription Drugs Market Share Analysis
Anti-Obesity Prescription Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Obesity Prescription Drugs business, the date to enter into the Anti-Obesity Prescription Drugs market, Anti-Obesity Prescription Drugs product introduction, recent developments, etc.
The major vendors covered:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
1 Study Coverage
- 1.1 Anti-Obesity Prescription Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Obesity Prescription Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type
- 1.4.2 Orlistat
- 1.4.3 Phentermine and Topiramate
- 1.4.4 Bupropion and Naltrexone
- 1.4.5 Lorcaserin
- 1.4.6 Liraglutide
- 1.5 Market by Application
- 1.5.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Application
- 1.5.2 Pediatric
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Obesity Prescription Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Obesity Prescription Drugs Revenue 2015-2026
- 2.1.2 Global Anti-Obesity Prescription Drugs Sales 2015-2026
- 2.2 Global Anti-Obesity Prescription Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Obesity Prescription Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Obesity Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Obesity Prescription Drugs Competitor Landscape by Players
- 3.1 Anti-Obesity Prescription Drugs Sales by Manufacturers
- 3.1.1 Anti-Obesity Prescription Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Obesity Prescription Drugs Revenue by Manufacturers
- 3.2.1 Anti-Obesity Prescription Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Obesity Prescription Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Obesity Prescription Drugs Revenue in 2019
- 3.2.5 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Obesity Prescription Drugs Price by Manufacturers
- 3.4 Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Obesity Prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Obesity Prescription Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Obesity Prescription Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Obesity Prescription Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Obesity Prescription Drugs Sales by Type (2015-2020)
- 4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Type (2015-2020)
- 4.1.3 Anti-Obesity Prescription Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Obesity Prescription Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Obesity Prescription Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Obesity Prescription Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Obesity Prescription Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Obesity Prescription Drugs Sales by Application (2015-2020)
- 5.1.2 Global Anti-Obesity Prescription Drugs Revenue by Application (2015-2020)
- 5.1.3 Anti-Obesity Prescription Drugs Price by Application (2015-2020)
- 5.2 Anti-Obesity Prescription Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Obesity Prescription Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Obesity Prescription Drugs by Country
- 6.1.1 North America Anti-Obesity Prescription Drugs Sales by Country
- 6.1.2 North America Anti-Obesity Prescription Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Obesity Prescription Drugs Market Facts & Figures by Type
- 6.3 North America Anti-Obesity Prescription Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Obesity Prescription Drugs by Country
- 7.1.1 Europe Anti-Obesity Prescription Drugs Sales by Country
- 7.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Obesity Prescription Drugs Market Facts & Figures by Type
- 7.3 Europe Anti-Obesity Prescription Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Obesity Prescription Drugs by Region
- 8.1.1 Asia Pacific Anti-Obesity Prescription Drugs Sales by Region
- 8.1.2 Asia Pacific Anti-Obesity Prescription Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Obesity Prescription Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Obesity Prescription Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Obesity Prescription Drugs by Country
- 9.1.1 Latin America Anti-Obesity Prescription Drugs Sales by Country
- 9.1.2 Latin America Anti-Obesity Prescription Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Obesity Prescription Drugs Market Facts & Figures by Type
- 9.3 Central & South America Anti-Obesity Prescription Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Obesity Prescription Drugs by Country
- 10.1.1 Middle East and Africa Anti-Obesity Prescription Drugs Sales by Country
- 10.1.2 Middle East and Africa Anti-Obesity Prescription Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-Obesity Prescription Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Obesity Prescription Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 F Hoffmann La Roche Ltd
- 11.1.1 F Hoffmann La Roche Ltd Corporation Information
- 11.1.2 F Hoffmann La Roche Ltd Description and Business Overview
- 11.1.3 F Hoffmann La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Products Offered
- 11.1.5 F Hoffmann La Roche Ltd Related Developments
- 11.2 Orexigen Therapeutics
- 11.2.1 Orexigen Therapeutics Corporation Information
- 11.2.2 Orexigen Therapeutics Description and Business Overview
- 11.2.3 Orexigen Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Products Offered
- 11.2.5 Orexigen Therapeutics Related Developments
- 11.3 Novo Nordisk A/s
- 11.3.1 Novo Nordisk A/s Corporation Information
- 11.3.2 Novo Nordisk A/s Description and Business Overview
- 11.3.3 Novo Nordisk A/s Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Products Offered
- 11.3.5 Novo Nordisk A/s Related Developments
- 11.4 Arena Pharmaceuticals
- 11.4.1 Arena Pharmaceuticals Corporation Information
- 11.4.2 Arena Pharmaceuticals Description and Business Overview
- 11.4.3 Arena Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Products Offered
- 11.4.5 Arena Pharmaceuticals Related Developments
- 11.5 Glaxosmithkline
- 11.5.1 Glaxosmithkline Corporation Information
- 11.5.2 Glaxosmithkline Description and Business Overview
- 11.5.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Products Offered
- 11.5.5 Glaxosmithkline Related Developments
- 11.6 Vivus
- 11.6.1 Vivus Corporation Information
- 11.6.2 Vivus Description and Business Overview
- 11.6.3 Vivus Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Vivus Anti-Obesity Prescription Drugs Products Offered
- 11.6.5 Vivus Related Developments
- 11.7 Boehringer Ingelheim
- 11.7.1 Boehringer Ingelheim Corporation Information
- 11.7.2 Boehringer Ingelheim Description and Business Overview
- 11.7.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Products Offered
- 11.7.5 Boehringer Ingelheim Related Developments
- 11.8 Alizyme
- 11.8.1 Alizyme Corporation Information
- 11.8.2 Alizyme Description and Business Overview
- 11.8.3 Alizyme Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Alizyme Anti-Obesity Prescription Drugs Products Offered
- 11.8.5 Alizyme Related Developments
- 11.1 F Hoffmann La Roche Ltd
- 11.1.1 F Hoffmann La Roche Ltd Corporation Information
- 11.1.2 F Hoffmann La Roche Ltd Description and Business Overview
- 11.1.3 F Hoffmann La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Products Offered
- 11.1.5 F Hoffmann La Roche Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Obesity Prescription Drugs Market Estimates and Projections by Region
- 12.1.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Obesity Prescription Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Obesity Prescription Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Obesity Prescription Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Obesity Prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Obesity Prescription Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Obesity Prescription Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Obesity Prescription Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Obesity Prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Obesity Prescription Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Obesity Prescription Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Obesity Prescription Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Obesity Prescription Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Obesity Prescription Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Obesity Prescription Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Obesity Prescription Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Obesity Prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Obesity Prescription Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Obesity Prescription Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Obesity Prescription Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Obesity Prescription Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Obesity Prescription Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Obesity Prescription Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Obesity Prescription Drugs. Industry analysis & Market Report on Anti-Obesity Prescription Drugs is a syndicated market report, published as Global Anti-Obesity Prescription Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-Obesity Prescription Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
